FT Tech Tonic
The risks and rewards of gene-editing
30 min•16 januari 2019
Om avsnittet
Robin Lovell-Badge, developmental biologist and geneticist, talks to FT science columnist Anjana Ahuja about the gene-edited babies controversy in China and about the potential for new gene-editing techniques to transform the treatment of diseases like cancer and muscular dystrophy.
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt
Visa alla avsnitt av FT Tech TonicFT Tech Tonic med Financial Times finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.